In keeping with this, our qPCR analyses revealed very low levels of IRX3 transcripts in all normal BM populations tested, but in 10 of 29 AML samples (34%), IRX3 expression was increased at least 250-fold over levels observed in the lowest expressing AML sample (Figure 1B; Table S1). Here, IRX3 is linked to acute myeloid leukemia.